Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?
- PMID: 33658323
- DOI: 10.1136/gutjnl-2021-324397
Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?
Keywords: 5-aminosalicylic acid (5-ASA); COVID-19; crohn's disease; inflammatory bowel disease; ulcerative colitis.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Effect of IBD medications on COVID-19 outcomes: results from an international registry.Gut. 2021 Apr;70(4):725-732. doi: 10.1136/gutjnl-2020-322539. Epub 2020 Oct 20. Gut. 2021. PMID: 33082265 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical